1. Home
  2. HOTH vs SFHG Comparison

HOTH vs SFHG Comparison

Compare HOTH & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • SFHG
  • Stock Information
  • Founded
  • HOTH 2017
  • SFHG 1993
  • Country
  • HOTH United States
  • SFHG Hong Kong
  • Employees
  • HOTH 3
  • SFHG N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • HOTH Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • HOTH 16.0M
  • SFHG 16.6M
  • IPO Year
  • HOTH 2019
  • SFHG 2024
  • Fundamental
  • Price
  • HOTH $1.44
  • SFHG $0.93
  • Analyst Decision
  • HOTH Strong Buy
  • SFHG
  • Analyst Count
  • HOTH 3
  • SFHG 0
  • Target Price
  • HOTH $4.00
  • SFHG N/A
  • AVG Volume (30 Days)
  • HOTH 733.2K
  • SFHG 50.4K
  • Earning Date
  • HOTH 05-12-2025
  • SFHG 07-15-2025
  • Dividend Yield
  • HOTH N/A
  • SFHG N/A
  • EPS Growth
  • HOTH N/A
  • SFHG N/A
  • EPS
  • HOTH N/A
  • SFHG N/A
  • Revenue
  • HOTH N/A
  • SFHG $19,760,935.00
  • Revenue This Year
  • HOTH N/A
  • SFHG N/A
  • Revenue Next Year
  • HOTH N/A
  • SFHG N/A
  • P/E Ratio
  • HOTH N/A
  • SFHG N/A
  • Revenue Growth
  • HOTH N/A
  • SFHG 30.89
  • 52 Week Low
  • HOTH $0.58
  • SFHG $0.55
  • 52 Week High
  • HOTH $3.80
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 62.68
  • SFHG N/A
  • Support Level
  • HOTH $1.17
  • SFHG N/A
  • Resistance Level
  • HOTH $1.34
  • SFHG N/A
  • Average True Range (ATR)
  • HOTH 0.10
  • SFHG 0.00
  • MACD
  • HOTH 0.02
  • SFHG 0.00
  • Stochastic Oscillator
  • HOTH 77.27
  • SFHG 0.00

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: